松龄血脉康治疗原发性高脂血症36例分析  

Treatment of Primary Hyperlipemia with Song Ling Xue Mai Kang

作　　者：张林虎[1] 胡丽华[1] 郑建业[1] 孙锡萍 

机构地区：[1]山西省人民医院,030012 [2]山西中日友好康复医疗中心

出　　处：《山西职工医学院学报》1997年第4期4-6,共3页Journal of Shanxi Medical College for Continuing Education

摘　　要：高脂血症尤高胆固醇血症作为冠心病的一个独立危险因素已为人知.本文旨在寻求一种安全有效的降脂药物,并对照观察了接受松龄血脉康与力平脂(Lipanthyl)治疗的86例原发性高脂血症患者4周后的血脂变化及不良反应,结果显示:两药在降总胆固醇(TC)和动脉粥样硬化指数(TG/HDL—C)方面作用相似,但在降低甘油三脂(TG)的程度上,血脉康作用较弱(P<0.05).然而总有效率相似.治疗期间松龄血脉康组未发现不良反应;力平脂组不良反应较弱.两组对肝、肾、造血系统功能均未发现不良影响.The purpose of this study is to find a safe and effective drug for primary hyper-lipemia. Of 86 patients with primary hyperlipemia, 36 were given Song Ling Xue Mai Kang(Song Ling Xue Mai Kang group) and 50 Lipanthyl(Lipanthy group). Comparisions were made between the two groups 4 weeks after the treatment. The results indicated that the two drugs had a similar action in reducing total cholesterol and atheroscleorsis and their total effective rates were similar to each other, but lipanthyl had a milder action of decreasing triglyceride. During the treatment , no adverse reactions were observed in the former group and only milder ones in the latter. In addition, no adverse effects on liver, kidneys, hematopoietic system were found in both groups.

关 键 词：原发性高脂血症 松龄血脉康 力平脂 

分 类 号：R259.892[医药卫生—中西医结合]